Table V.
Further information concerning the 5 FHypeMR and 6 FHypoMR.
| Marker ID | Chromosomal location NCBI36/hg18 | Associated gene |
|---|---|---|
| FHypeMR 1 | Chr4:81,219,256-81,219,713 | Anthrax toxin receptor 2 (ANTXR2) |
| FHypeMR 2 | Chr6:50,894,411-50,894,837 | Transcription factor AP-2β (TFAP2B) |
| FHypeMR 3 | Chr21:38,791,187-38,792,106 | Erythroblastosis virus E26 oncogene homolog (ERG) |
| FHypeMR 4 | Chr7:35,261,345-35,261,771 | T-box 20 (TBX20) |
| FHypeMR 5 | Chr22:25,205,384-25,205,989 | Hermansky-Pudlak syndrome 4 (HPS4) |
| FHypoMR 1 | Chr1:41,215,030-41,215,734 | Cytidine triphosphate synthase (CTPS) |
| FHypoMR 2 | ChrX:28,517,115-28,517,628 | Interleukin 1 receptor accessory protein-like 1 (IL1RAPL1) |
| FHypoMR 3 | Chr6:132,312,025-132,312,573 | Connective tissue growth factor (CTGF) |
| FHypoMR 4 | Chr1:10,194,437-10,194,830 | Kinesin family member 1B (KIF1B) |
| FHypoMR 5 | Chr6:6,267,573-6,268,106 | Coagulation factor XIII, A1 polypeptide (F13A1) |
| FHypoMR 6 | Chr13:72,527,950-72,528,544 | Kruppel-like factor 5 (KLF5) |
Chr, chromosome; FHypeMR, fetus hypermethylation regions; FHypoMR, fetus hypomethylation regions.